通过PRAME表达在黑色素瘤中的治疗机会
Mislav Mokos1, Ivana Prkačin1,2, Klara Gaćina1
1Department of Dermatology and Venereology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Biomedicines
|August 28, 2025
概括
在黑色素瘤中优先表达的抗原 (PRAME) 是诊断黑色素瘤的有价值生物标志物,也是免疫治疗的有希望的目标,有助于个性化治疗癌症.
科学领域:
- 癌症学
- 免疫学
- 皮肤病理学
背景情况:
- 由于与良性病变的相似性, 诊断黑色素瘤是具有挑战性的.
- 免疫组织化学 (IHC) 在困难的情况下有助于诊断.
- 在黑色素瘤中优先表达的抗原 (PRAME) 是一个关键标志物.
研究的目的:
- 审查PRAME在黑色素瘤诊断,预后和治疗中的作用.
- 评估PRAME的诊断效用与良性瘤.
- 探索PRAME在免疫治疗中的治疗潜力.
主要方法:
- 在黑色细胞病变和恶性瘤中PRAME表达的文献综述.
- 对PRAME与IHC协议的整合进行分析.
- 对以PRAME为导向的试验疗法的评估.
主要成果:
- 在分辨黑色素瘤亚型方面,PRAME具有很高的特异性和敏感性.
- 在恶性瘤中,PRAME过度表达与预后不佳相关.
- 通过PRAME指导的疗法显得有前途, 但面临着免疫规避等挑战.
结论:
- PRAME是黑色素瘤诊断的重要生物标志物,也是免疫治疗的目标.
- 支持诊断精度,预后评估和精度瘤学的临床实用性.
- 克服免疫规避对于优化PRAME导向治疗至关重要.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


